# Research progress on mitochondria in bone defect repair: mechanisms and therapeutic implications

**Authors:** Zhicheng Hu, Gang Chen, Zhisheng Long

PMC · DOI: 10.3389/fbioe.2026.1763027 · Frontiers in Bioengineering and Biotechnology · 2026-02-05

## TL;DR

This paper reviews how mitochondria influence bone repair and suggests new treatment strategies targeting mitochondria for better outcomes.

## Contribution

The paper systematically reviews mitochondrial mechanisms in bone defect repair and proposes novel mitochondria-targeted strategies.

## Key findings

- Mitochondria regulate key bone cells through OXPHOS, ROS, and Ca2+.
- Mitochondria interact with the neuro-vascular-muscle axis during repair.
- Targeting mitochondria could lead to more effective and safe bone treatments.

## Abstract

Bone defect repair faces clinical challenges due to complex conditions caused by various factors such as trauma and aging. Traditional treatments have certain limitations, which seriously affect patients’ prognosis. As the core organelle of cells, mitochondria regulate the activity of key cells including osteoblasts, osteoclasts, and bone marrow mesenchymal stem cells through functions such as oxidative phosphorylation (OXPHOS), production and scavenging of reactive oxygen species (ROS), regulation of Ca2+ concentration, modulation of cell death, and immune response, as well as dynamic processes including fusion, fission, mitophagy, and transport. Moreover, mitochondria interact synergistically with the neuro-vascular-muscle axis, participating deeply in bone defect repair. This article systematically reviews the mechanisms and research progress of mitochondria in bone defect repair, providing a theoretical basis for the development of novel mitochondria-targeted repair strategies and facilitating the research and development of efficient clinical treatment regimens. This will help to develop new treatment strategies for bone defects. These strategies will be more effective, safe and targeted for individual patients.

## Full-text entities

- **Genes:** TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, NPY (neuropeptide Y) [NCBI Gene 4852] {aka PYY4}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, DHX58 (DExH-box helicase 58) [NCBI Gene 79132] {aka D11LGP2, D11lgp2e, LGP2, RLR-3}, Dnm1l (dynamin 1-like) [NCBI Gene 74006] {aka 6330417M19Rik, Dlp1, Dnmlp1, Drp1, python}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, CAT [NCBI Gene 6155852], ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, MFN2 (mitofusin 2) [NCBI Gene 9927] {aka CMT2A, CMT2A2, CMT2A2A, CMT2A2B, CPRP1, HMSN6A}, NOX1 (NADPH oxidase 1) [NCBI Gene 27035] {aka GP91-2, MOX1, NOH-1, NOH-1L, NOH1}, RHOT1 (ras homolog family member T1) [NCBI Gene 55288] {aka ARHT1, MIRO-1, MIRO1}, Ptger4 (prostaglandin E receptor 4 (subtype EP4)) [NCBI Gene 19219] {aka EP4, Ptgerep4}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TRAK1 (trafficking kinesin protein 1) [NCBI Gene 22906] {aka DEE68, EIEE68, MILT1, OIP106}, OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 4976] {aka BERHS, MGM1, MTDPS14, MTDPS14A, MTDPS14B, NPG}, TAC1 (tachykinin precursor 1) [NCBI Gene 6863] {aka Hs.2563, NK2, NKNA, NPK, TAC2}, MIR126 (microRNA 126) [NCBI Gene 406913] {aka MIRN126, miRNA126, mir-126}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551] {aka IKK-2, IKK-beta, IKK2, IKKB, IMD15, IMD15A}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, EIF2A (eukaryotic translation initiation factor 2A) [NCBI Gene 83939] {aka CDA02, EIF-2A, MST089, MSTP004, MSTP089}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, IL2RB (interleukin 2 receptor subunit beta) [NCBI Gene 3560] {aka CD122, IL15RB, IMD63, P70-75}, CHUK (component of inhibitor of nuclear factor kappa B kinase complex) [NCBI Gene 1147] {aka BPS2, IKBKA, IKK-1, IKK-alpha, IKK1, IKKA}, LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, DNM1L (dynamin 1 like) [NCBI Gene 10059] {aka DLP1, DRP1, DVLP, DYMPLE, EMPF, EMPF1}, HSPD1 (heat shock protein family D (Hsp60) member 1) [NCBI Gene 3329] {aka CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, MAPKAPK2 (MAPK activated protein kinase 2) [NCBI Gene 9261] {aka MAPKAP-K2, MK-2, MK2}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, CYBB (cytochrome b-245 beta chain) [NCBI Gene 1536] {aka AMCBX2, CGD, CGDX, GP91-1, GP91-PHOX, GP91PHOX}, REPIN1 (replication initiator 1) [NCBI Gene 29803] {aka AP4, RIP60, ZNF464, Zfp464}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, FIS1 (fission, mitochondrial 1) [NCBI Gene 51024] {aka CGI-135, TTC11}, KIF5B (kinesin family member 5B) [NCBI Gene 3799] {aka HEL-S-61, KINH, KNS, KNS1, UKHC}, USP30 (ubiquitin specific peptidase 30) [NCBI Gene 84749], DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, APAF1 (apoptotic peptidase activating factor 1) [NCBI Gene 317] {aka APAF-1, CED4}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MCU (mitochondrial calcium uniporter) [NCBI Gene 90550] {aka C10orf42, CCDC109A, HsMCU}, MFN1 (mitofusin 1) [NCBI Gene 55669] {aka hfzo1, hfzo2}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}
- **Diseases:** infected (MESH:D007239), cardiovascular diseases (MESH:D002318), bone defect (MESH:D001847), osteoporosis (MESH:D010024), vascular calcification (MESH:D061205), malnutrition (MESH:D044342), skeletal developmental disorders (MESH:D002658), bacterial infections (MESH:D001424), neuronal damage (MESH:D009410), resorption (MESH:D014091), muscle injury (MESH:D009135), calcification (MESH:D002114), cancer (MESH:D009369), traumatic brain injury (MESH:D000070642), osteoporotic (MESH:D058866), osteogenesis imperfecta (MESH:D010013), Osteogenic (MESH:D012516), inflammation (MESH:D007249), neurodegenerative diseases (MESH:D019636), trauma (MESH:D014947), iron overload (MESH:D019190), bone tumour (MESH:D001859), fractures (MESH:D050723), Mitochondrial dysfunction (MESH:D028361), osteoarthritis (MESH:D010003), congenital bone malformations (MESH:D001848), hypoxia (MESH:D000860), diabetic non-union (MESH:D017759), abnormal bone metabolism (MESH:D001851), hypoxic (MESH:D002534)
- **Chemicals:** amino acids (MESH:D000596), hydroxyapatite (MESH:D017886), Flavin Adenine Dinucleotide (MESH:D005182), 1O2 (-), superoxide (MESH:D013481), H2O2 (MESH:D006861), melatonin (MESH:D008550), proton (MESH:D011522), NAD  + (MESH:D009243), H+ (MESH:D006859), diterpene (MESH:D004224), glucose (MESH:D005947), sphingosine (MESH:D013110), calcium (MESH:D002118), ROS (MESH:D017382), FADH2 (MESH:C058805), ATP (MESH:D000255), GSH (MESH:D005978), lipid (MESH:D008055), antimycin A (MESH:D000968), OH (MESH:C031356), ADP (MESH:D000244), tricarboxylic acid (MESH:D014233), rapamycin (MESH:D020123), singlet oxygen (MESH:D026082), phosphate (MESH:D010710), Pi (MESH:D010716), phosphorus (MESH:D010758), oxygen (MESH:D010100), vitamin C. (MESH:D001205), FK866 (MESH:C480543), hydroxyl radical (MESH:D017665), water (MESH:D014867), 2-thiouridine (MESH:C105273), Iron (MESH:D007501)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916668/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916668/full.md

## References

97 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916668/full.md

---
Source: https://tomesphere.com/paper/PMC12916668